NACCMENACCME
Pharmacy Learning NetworkManaged Care ConsultantCoalition of Rheumatology Educators (CORE)CME ForumCE ForumSAWCPrinceton Teleconference Series

Testing Center

Combating the HIV/AIDS Epidemic: Managing Barriers to Optimal Care

Combating the HIV/AIDS Epidemic: Managing Barriers to Optimal Care

On-Demand Video Webcast

NACCME

Sponsored by North American Center for Continuing Medical Education, LLC

Supported by an educational grant from Bristol-Myers Squibb Company

Faculty Presenter

Edwin DeJesus, MD, FACP
Medical Director
Orlando Immunology Center
Orlando, Florida

Target Audience

This activity is designed for infectious diseases specialists, and other physicians, nurses and related professionals, involved in the management of HIV/AIDS.

Learning Objectives

After completing this activity, participants should be able to:

  • Identify issues that can negatively impact outcomes in HIV patients, including patient nonadherence, and discuss practical solutions to minimize these issues
  • Describe the importance of how management of integrated HIV comorbidities, such as concomitant HCV, can effect early, initial ARV treatment decisions and impact long term treatment outcomes
  • Discuss how to best manage the development of resistance in HIV-positive patients  and the clinical value of HIV resistance testing to promote appropriate treatment
  • Individualize ARV therapy to specific patient demographics and characteristics
  • Implement current treatment guidelines and recent data (ICAAC/IDSA) for optimal management of HIV patients, with focus on treatment initiation and selection

Activity Overview

This on-demand video cast is available with synchronized slides and video.

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at http://www.naccme.com/program/2010-376-3/post/, participants may immediately print their documentation of credit.
There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
 
Release Date: June 30, 2010

Expiration Date: June 30, 2011  

Estimated time to complete: 1 hour

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This continuing nursing education activity was approved for 1 contact hour. 

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1 contact hour.

Independent Clinical Reviewer: John F. Toney, MD, FACP, FIDSA, Professor of Medicine, Division of Infectious Diseases and International Medicine, Medical Director, Florida Infectious Disease Institute, University of South Florida College of Medicine, Medical Director, Southeast STD/HIV Prevention Training Center, CDC National Network of STD/HIV Prevention Training Centers, Director of Healthcare Epidemiology and Infectious Diseases Clinical Research, James A. Haley Veterans' Hospital, Tampa, Florida

Nurse Reviewer: Melanie Steilen, BSN, RN, ACRN, Director of Nursing Education, Cicatelli Associates Inc., New York, New York, Director at Large, Association of Nurses in AIDS Care, Akron, Ohio.

Planning Committee

The planning committee comprises, Edwin DeJesus, MD, FACP; Charles Hicks, MD; John F. Toney, MD, FACP, FIDSA; Melanie Steilen, BSN, RN, ACRN; Mike Kearney, Donna Kruggel, Emilie McCardell, Greg Paladino, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest  

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
                
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:

Dr. DeJesus: Grant/Research Support—Abbott Laboratories, Achillion, Avexa, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Hoffman La Roche Laboratories, Merck, Pfizer, Schering Plough, Taimed, Tobira, Tibotec, Vertex; Consultant—Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Tibotec, Vertex Pharmaceuticals; Speakers Bureau—Gilead Sciences, Merck, Tibotec, Virco
Dr. Hicks: Grant/Research Support—Argos, Gilead, Merck, Myriad Pharmaceuticals, Pfizer, Tibotec, ViiV; Consultant—Bristol-Myers Squibb, Gilead, Merck, Tibotec, ViiV; Scientific Advisor—Myriad Pharmaceuticals
Dr. Toney: Has disclosed no relevant financial relationships with any commercial interests.
Ms. Steilen: Has disclosed no relevant financial relationships with any commercial interests.

Mr. Kearney, Ms. Kruggel, Ms. McCardell, Mr. Robbin, Mr. Paladino, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Bristol-Myers Squibb Company

Program Components

Introduction

Pre-Test

Webcast

Post-Test



   

©Copyright 2003-2010 NACCME   Privacy Policy
Hardware/Software Requirements Disclosure Statement